封面
市場調查報告書
商品編碼
1890931

實驗室晶片市場按產品/服務、技術、應用、最終用戶和地區分類

Lab on Chip Market, By Product and Service, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年,實驗室晶片市場價值將達到 72.1 億美元,到 2032 年將達到 138.7 億美元,2025 年至 2032 年的複合年成長率為 9.8%。

報告內容 報告詳情
基準年: 2024 2025年市場規模: 72.1億美元
歷史數據時期: 2020年至2024年 預測期: 2025年至2032年
預測期(2025-2032年)複合年成長率: 9.80% 預計2032年價值: 138.7億美元

全球實驗室晶片市場代表著微流體、生物技術和分析化學的創新融合,從根本上改變了醫療、製藥和生命科學領域的診斷和調查方法。

實驗室晶片(LOC)技術,也稱為微流體裝置,將多種實驗室功能整合到尺寸僅為幾毫米到幾厘米的單一晶片上,從而以前所未有的精度和效率實現生物樣品分析的微型化。這些先進的裝置利用微通道、幫浦、混合器和檢測器,在可控制的微環境中執行複雜的生化過程,包括樣品製備、反應、分離和檢測。

憑藉樣本量少、試劑消費量低、分析時間短、通量高等特點,這項技術已成為現代即時診斷和個人化醫療的基礎技術。隨著全球醫療系統日益重視快速、準確且經濟高效的診斷解決方案,尤其是在新冠疫情凸顯分散式檢查能力重要性的背景下,實驗室晶片平台已成為下一代醫療設備的關鍵基礎技術,支援從感染疾病檢測、癌症生物標記分析到環境監測和藥物研發等廣泛應用。

市場動態

全球實驗室晶片市場由多個強勁促進因素推動,這些因素凸顯了其在多個行業中的變革潛力。慢性病和感染疾病的日益增加以及全球人口老化,使得快速、精準的診斷解決方案需求巨大,而實驗室晶片技術憑藉其小型化、便攜性和經濟高效的檢測能力,提供了一種獨特的解決方案。

醫療保健數位化和個人化醫療的趨勢正在進一步推動市場成長,LOC設備能夠實現精準的生物標記檢測、基因分析和藥物篩檢,這些對於個人化治療方案至關重要。此外,新興經濟體醫療費用支出的成長,以及政府為促進就地檢驗基礎設施建設而採取的舉措,也創造了巨大的成長機會。

然而,微流控裝置市場存在許多限制因素,包括高昂的初始研發成本、複雜的監管核准流程以及與裝置標準化和生產擴充性相關的技術挑戰。微流體裝置的製造需要先進的專業技術和製造設施,這可能會限制中小企業進入市場,並阻礙其廣泛應用。

此外,設備可靠性、交叉污染風險以及操作複雜系統需要熟練人員等問題可能會阻礙晶片實驗室技術在資源匱乏地區的市場滲透。儘管有這些挑戰,奈米技術的日益融合、人工智慧在增強數據分析方面的應用,以及在環境監測、食品安全檢測和藥物研發等領域的不斷拓展,都帶來了巨大的機會。預計這將推動實驗室晶片市場的持續成長和技術進步。

本次調查的主要特點

  • 本報告對全球實驗室晶片市場進行了詳細分析,以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模(十億美元)和復合年成長率(%)。
  • 它還重點介紹了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本報告根據以下參數對全球實驗室晶片市場的主要企業進行了分析:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球實驗室晶片市場報告的目標受眾是該行業的各類相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過全球實驗室晶片市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 重大進展
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特分析
  • 併購趨勢
  • 產業趨勢

4. 2020-2032年全球實驗室晶片)

  • 試劑及耗材(晶片、試劑盒、微孔盤、檢測試劑盒等)
  • 軟體和服務(數據分析、遠端監控、工作流程自動化等)
  • 裝置及儀器(微流體晶片、感測器、致動器等)

5. 2020-2032年全球實驗室晶片)

  • 微陣列
  • 微流體技術
  • 組織生物晶片
  • 其他(新興或混合技術)

6. 2020-2032年全球實驗室晶片市場(依應用領域分類)

  • 基因組學
  • 蛋白質體學
  • 診斷
  • 藥物發現
  • 就地檢驗
  • 其他

7. 2020-2032年全球實驗室晶片)

  • 醫院和診所
  • 生物技術和製藥公司
  • 診斷中心
  • 合約研究組織(CRO)
  • 法醫學研究所
  • 居家醫療環境
  • 其他(學術和研究機構)

8. 2020-2032年全球實驗室晶片市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第9章 競爭情勢

  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • BioMerieux
  • Danaher Corporation
  • PerkinElmer
  • Illumina
  • QIAGEN
  • Merck Group
  • Roche Diagnostics
  • Becton Dickinson(BD)
  • Tecan Group
  • Luminex Corporation
  • Fluidigm Corporation

第10章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8825

Lab on Chip Market is estimated to be valued at USD 7.21 Bn in 2025 and is expected to reach USD 13.87 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 7.21 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.80% 2032 Value Projection: USD 13.87 Bn

The global lab on chip market represents a revolutionary convergence of microfluidics, biotechnology, and analytical chemistry, fundamentally transforming diagnostic and research methodologies across healthcare, pharmaceutical, and life sciences sectors.

Lab-on-chip (LOC) technology, also known as microfluidic devices, integrates multiple laboratory functions onto a single chip measuring just millimeters to a few centimeters in size, enabling miniaturized analysis of biological samples with unprecedented precision and efficiency. These sophisticated devices leverage microchannels, pumps, mixers, and detectors to perform complex biochemical processes including sample preparation, reaction, separation, and detection within a controlled microenvironment.

The technology's ability to reduce sample volumes, minimize reagent consumption, accelerate analysis time, and deliver high-throughput capabilities has positioned it as a cornerstone of modern point-of-care diagnostics and personalized medicine initiatives. As healthcare systems worldwide increasingly prioritize rapid, accurate, and cost-effective diagnostic solutions, particularly following the COVID-19 pandemic's emphasis on decentralized testing capabilities, lab-on-chip platforms have emerged as critical enablers of next-generation medical devices, supporting applications ranging from infectious disease detection and cancer biomarker analysis to environmental monitoring and drug discovery processes.

Market Dynamics

The global lab on chip market is propelled by several compelling drivers that underscore its transformative potential across multiple industries. The increasing prevalence of chronic diseases, infectious diseases, and the growing aging population worldwide creates substantial demand for rapid, accurate diagnostic solutions that lab-on-chip technology uniquely provides through its miniaturized, portable, and cost-effective testing capabilities.

Healthcare digitization trends and the shift toward personalized medicine further accelerate market growth, as LOC devices enable precise biomarker detection, genetic analysis, and drug screening applications essential for tailored therapeutic approaches. Additionally, rising healthcare expenditure in emerging economies, coupled with government initiatives promoting point-of-care testing infrastructure, creates significant market expansion opportunities.

However, the market faces notable restraints including high initial development costs, complex regulatory approval processes, and technical challenges related to device standardization and manufacturing scalability. The sophisticated nature of microfluidic device fabrication requires specialized expertise and advanced manufacturing facilities, potentially limiting market accessibility for smaller companies and creating barriers to widespread adoption.

Furthermore, concerns regarding device reliability, cross-contamination risks, and the need for skilled personnel to operate complex systems may hinder market penetration in resource-limited settings. Despite these challenges, substantial opportunities emerge from advancing nanotechnology integration, artificial intelligence incorporation for enhanced data analysis, and expanding applications in environmental monitoring, food safety testing, and pharmaceutical research, positioning the lab-on-chip market for sustained growth and technological evolution.

Key Features of the Study

  • This report provides in-depth analysis of the global lab on chip market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lab on chip market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, BioMerieux, Danaher Corporation, PerkinElmer, Illumina, QIAGEN, Merck Group, Roche Diagnostics, Becton Dickinson (BD), Tecan Group, Luminex Corporation, and Fluidigm Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lab on chip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lab on chip market

Market Segmentation

  • Product and Service Insights (Revenue, USD Bn, 2020 - 2032)
    • Reagents and Consumables (chips, cartridges, microplates, assay kits, etc.)
    • Software and Services (data analytics, remote monitoring, workflow automation, etc.)
    • Devices and Instruments (microfluidic chips, sensors, actuators, etc.)
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Microarrays
    • DNA Microarrays (Gene Chips)
    • Protein Microarrays
    • Antibody Microarrays
    • Microfluidics
    • Continuous-flow Microfluidics
    • Droplet-based Microfluidics (Digital Microfluidics)
    • Optofluidics
    • Acoustofluidics
    • Tissue Biochip
    • 2D Cell Culture Chips
    • 3D Cell Culture and Organ-on-a-Chip
    • Others (emerging or hybrid technologies)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
    • Point-of-Care Testing
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals and Clinics
    • Biotechnology and Pharmaceutical Companies
    • Diagnostic Centers
    • Contract Research Organizations (CROs)
    • Forensic Laboratories
    • Home Care Settings
    • Others (Academic and Research Institutes)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Agilent Technologies
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific
    • BioMerieux
    • Danaher Corporation
    • PerkinElmer
    • Illumina
    • QIAGEN
    • Merck Group
    • Roche Diagnostics
    • Becton Dickinson (BD)
    • Tecan Group
    • Luminex Corporation
    • Fluidigm Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lab on Chip Market, By Product and Service
    • Global Lab on Chip Market, By Technology
    • Global Lab on Chip Market, By Application
    • Global Lab on Chip Market, By End User
    • Global Lab on Chip Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lab on Chip Market, By Product and Service, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Reagents and Consumables (chips, cartridges, microplates, assay kits, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Software and Services (data analytics, remote monitoring, workflow automation, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Devices and Instruments (microfluidic chips, sensors, actuators, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Lab on Chip Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • DNA Microarrays (Gene Chips)
      • Protein Microarrays
      • Antibody Microarrays
  • Microfluidics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Continuous-flow Microfluidics
      • Droplet-based Microfluidics (Digital Microfluidics)
      • Optofluidics
      • Acoustofluidics
  • Tissue Biochip
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • 2D Cell Culture Chips
      • 3D Cell Culture and Organ-on-a-Chip
  • Others (emerging or hybrid technologies)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Lab on Chip Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Point-of-Care Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lab on Chip Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Forensic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Academic and Research Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lab on Chip Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioMerieux
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton Dickinson (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Tecan Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Luminex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fluidigm Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us